• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草酰异羟肟酸酯作为酮醇酸还原异构酶的反应中间体类似物

Oxalyl hydroxamates as reaction-intermediate analogues for ketol-acid reductoisomerase.

作者信息

Aulabaugh A, Schloss J V

机构信息

Central Research and Development Department, E. I. du Pont de Nemours and Company, Wilmington, Delaware 19880-0328.

出版信息

Biochemistry. 1990 Mar 20;29(11):2824-30. doi: 10.1021/bi00463a027.

DOI:10.1021/bi00463a027
PMID:2189496
Abstract

N-Hydroxy-N-isopropyloxamate (IpOHA) is an exceptionally potent inhibitor of the Escherichia coli ketol-acid reductoisomerase. In the presence of Mg2+ or Mn2+, IpOHA inhibits the enzyme in a time-dependent manner, forming a nearly irreversible complex. Nucleotide, which is essential for catalysis, greatly enhances the binding of IpOHA by the reductoisomerase, with NADPH (normally present during the enzyme's rearrangement step, i.e., conversion of a beta-keto acid into an alpha-keto acid, in either the forward or reverse physiological reactions) being more effective than NADP. In the presence of Mg2+ and NADPH, IpOHA appears to bind to the enzyme in a two-step mechanism, with an initial inhibition constant of 160 nM and a maximum rate of formation of the tight, slowly reversible complex of 0.57 min-1 (values that give an association rate of IpOHA, at low concentration, of 5.9 X 10(4) M-1 s-1). The rate of exchange of [14C]IpOHA from an enzyme-[14C]IpOHA-Mg2(+)-NADPH complex with exogenous, unlabeled IpOHA has a half-time of 6 days (150 h). This dissociation rate (1.3 X 10(-6) s-1) and the association rate determined by inactivation kinetics define an overall dissociation constant of 22 pM. By contrast, in the presence of Mn2+ and NADPH, the corresponding association and dissociation rates for IpOHA are 8.2 X 10(4) M-1 s-1 and 3.2 X 10(-6) s-1 (half-time = 2.5 days), respectively, which define an overall dissociation constant of 38 pM. In the presence of NADP or in the absence of nucleotide (both in the presence of Mg2+), the enzyme-IpOHA complex is far more labile, with dissociation half-times of 28 and 2 h, respectively. In the absence of Mg2+ or Mn2+, IpOHA does not exhibit time-dependent inhibition of the reductoisomerase.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

N-羟基-N-异丙基草氨酸(IpOHA)是大肠杆菌酮醇酸还原异构酶的一种极其有效的抑制剂。在Mg2+或Mn2+存在的情况下,IpOHA以时间依赖性方式抑制该酶,形成一种几乎不可逆的复合物。对催化至关重要的核苷酸极大地增强了还原异构酶对IpOHA的结合,其中NADPH(通常在酶的重排步骤中存在,即在正向或反向生理反应中β-酮酸转化为α-酮酸的过程中)比NADP更有效。在Mg2+和NADPH存在的情况下,IpOHA似乎以两步机制与酶结合,初始抑制常数为160 nM,紧密的、缓慢可逆复合物的最大形成速率为0.57 min-1(这些值在低浓度下给出IpOHA的缔合速率为5.9×10(4) M-1 s-1)。[14C]IpOHA从酶-[14C]IpOHA-Mg2(+)-NADPH复合物与外源未标记的IpOHA的交换速率的半衰期为6天(150小时)。这种解离速率(1.3×10(-6) s-1)和通过失活动力学确定的缔合速率定义了一个整体解离常数为22 pM。相比之下,在Mn2+和NADPH存在的情况下,IpOHA相应的缔合和解离速率分别为8.2×10(4) M-1 s-1和3.2×10(-6) s-1(半衰期 = 2.5天),这定义了一个整体解离常数为38 pM。在NADP存在或不存在核苷酸的情况下(两者都在Mg2+存在时),酶-IpOHA复合物更加不稳定,解离半衰期分别为28小时和2小时。在没有Mg2+或Mn2+的情况下,IpOHA不会表现出对还原异构酶的时间依赖性抑制。(摘要截短于250字)

相似文献

1
Oxalyl hydroxamates as reaction-intermediate analogues for ketol-acid reductoisomerase.草酰异羟肟酸酯作为酮醇酸还原异构酶的反应中间体类似物
Biochemistry. 1990 Mar 20;29(11):2824-30. doi: 10.1021/bi00463a027.
2
Interactions of plant acetohydroxy acid isomeroreductase with reaction intermediate analogues: correlation of the slow, competitive, inhibition kinetics of enzyme activity and herbicidal effects.植物乙酰羟酸异构还原酶与反应中间类似物的相互作用:酶活性的缓慢竞争性抑制动力学与除草效果的相关性
Biochem J. 1994 Aug 1;301 ( Pt 3)(Pt 3):813-20. doi: 10.1042/bj3010813.
3
Crystal Structures of Staphylococcus aureus Ketol-Acid Reductoisomerase in Complex with Two Transition State Analogues that Have Biocidal Activity.金黄色葡萄球菌酮醇酸还原异构酶与两种具有杀菌活性的过渡态类似物复合物的晶体结构
Chemistry. 2017 Dec 22;23(72):18289-18295. doi: 10.1002/chem.201704481. Epub 2017 Nov 30.
4
Characterization of the conformational changes of acetohydroxy acid isomeroreductase induced by the binding of Mg2+ ions, NADPH, and a competitive inhibitor.镁离子、NADPH和一种竞争性抑制剂结合诱导乙酰羟酸异构还原酶构象变化的表征
Biochemistry. 1999 May 11;38(19):6025-34. doi: 10.1021/bi982412e.
5
Mechanism of ketol acid reductoisomerase--steady-state analysis and metal ion requirement.
Biochemistry. 1989 Jan 24;28(2):486-93. doi: 10.1021/bi00428a012.
6
Facile crystallization of Escherichia coli ketol-acid reductoisomerase.大肠杆菌酮醇酸还原异构酶的简易结晶
Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1432-4. doi: 10.1107/S0907444904012247. Epub 2004 Jul 21.
7
Inhibition studies of ketol-acid reductoisomerases from pathogenic microorganisms.抑制致病性微生物中的酮酸-醛还原异构酶的研究。
Arch Biochem Biophys. 2020 Oct 15;692:108516. doi: 10.1016/j.abb.2020.108516. Epub 2020 Aug 1.
8
Conformational changes in a plant ketol-acid reductoisomerase upon Mg(2+) and NADPH binding as revealed by two crystal structures.两种晶体结构揭示植物酮醇酸还原异构酶在结合Mg(2+)和NADPH后的构象变化
J Mol Biol. 2009 May 29;389(1):167-82. doi: 10.1016/j.jmb.2009.04.012. Epub 2009 Apr 9.
9
Crystal structure of Mycobacterium tuberculosis ketol-acid reductoisomerase at 1.0 Å resolution - a potential target for anti-tuberculosis drug discovery.结核分枝杆菌酮酸还原异构酶的晶体结构分辨率为 1.0 Å-抗结核药物发现的潜在靶点。
FEBS J. 2016 Apr;283(7):1184-96. doi: 10.1111/febs.13672. Epub 2016 Feb 18.
10
Stepwise building of a 115-kDa macromolecular edifice monitored by electrospray mass spectrometry. The case of acetohydroxy acid isomeroreductase.通过电喷雾质谱监测115 kDa大分子结构的逐步构建。以乙酰羟酸异构还原酶为例。
Eur J Biochem. 1999 Jan;259(1-2):356-9. doi: 10.1046/j.1432-1327.1999.00046.x.

引用本文的文献

1
A Ketol-Acid Reductoisomerase Inhibitor That Has Antituberculosis and Herbicidal Activity.一种具有抗结核和除草活性的酮醇酸还原异构酶抑制剂。
Chemistry. 2025 Jun 26;31(36):e202501158. doi: 10.1002/chem.202501158. Epub 2025 Jun 9.
2
Studies on the synthesis, crystal structures, biological activities and molecular docking of novel natural methylxanthine derivatives containing piperazine moiety.含哌嗪部分的新型天然甲基黄嘌呤衍生物的合成、晶体结构、生物活性及分子对接研究
Mol Divers. 2025 Jun;29(3):2129-2142. doi: 10.1007/s11030-024-10972-z. Epub 2024 Nov 7.
3
Dihydroxy-Acid Dehydratases From Pathogenic Bacteria: Emerging Drug Targets to Combat Antibiotic Resistance.
致病细菌中的二羟酸脱水酶:用于对抗抗生素耐药性的新兴药物靶点。
Chemistry. 2022 Aug 4;28(44):e202200927. doi: 10.1002/chem.202200927. Epub 2022 Jun 16.
4
Comparative proteomics of three Chinese potato cultivars to improve understanding of potato molecular response to late blight disease.三种中国马铃薯品种的比较蛋白质组学,以增进对马铃薯对晚疫病分子反应的理解。
BMC Genomics. 2020 Dec 9;21(1):880. doi: 10.1186/s12864-020-07286-3.
5
Targeting Metalloenzymes for Therapeutic Intervention.靶向金属酶治疗干预。
Chem Rev. 2019 Jan 23;119(2):1323-1455. doi: 10.1021/acs.chemrev.8b00201. Epub 2018 Sep 7.
6
Bacterial Branched-Chain Amino Acid Biosynthesis: Structures, Mechanisms, and Drugability.细菌支链氨基酸生物合成:结构、机制及成药潜力
Biochemistry. 2017 Nov 7;56(44):5849-5865. doi: 10.1021/acs.biochem.7b00849.
7
General approach to reversing ketol-acid reductoisomerase cofactor dependence from NADPH to NADH.将酮酸还原异构酶辅酶依赖从 NADPH 转换为 NADH 的一般方法。
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):10946-51. doi: 10.1073/pnas.1306073110. Epub 2013 Jun 17.
8
Virtual screening and evaluation of Ketol-Acid Reducto-Isomerase (KARI) as a putative drug target for Aspergillosis.虚拟筛选和评估酮酸还原异构酶(KARI)作为曲霉菌病的潜在药物靶点。
Clin Proteomics. 2012 Feb 3;9(1):1. doi: 10.1186/1559-0275-9-1.
9
Synthesis, structure, and biological activity of novel (oxdi/tri)azoles derivatives containing 1,2,3-thiadiazole or methyl moiety.新型(氧杂/三唑)衍生物中含 1,2,3-噻二唑或甲基部分的合成、结构和生物活性。
Mol Divers. 2012 May;16(2):251-60. doi: 10.1007/s11030-011-9352-z. Epub 2012 Jan 17.
10
Nitrosative stress treatment of E. coli targets distinct set of thiol-containing proteins.对大肠杆菌进行亚硝化应激处理会靶向一组不同的含硫醇蛋白。
Mol Microbiol. 2007 Nov;66(4):901-14. doi: 10.1111/j.1365-2958.2007.05964.x. Epub 2007 Oct 5.